Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 18;66(Pt 9):o2339.
doi: 10.1107/S1600536810032186.

N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea

N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea

Alan J Lough et al. Acta Crystallogr Sect E Struct Rep Online. .

Abstract

The title compound, C(11)H(10)N(4)O(4)S, is a derivative of N-(4-meth-oxy-benz-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea (AR-A014418), a known glycogen synthase kinase 3β (GSK-3β) inhibitor. All non-H atoms in the mol-ecule are essentially coplanar, with an r.m.s. deviation of 0.045 Å and a maximum deviation of 0.115 (2) Å for the carbonyl O atom. In the crystal structure, mol-ecules are linked via N-H⋯O hydrogen bonds into one-dimensional chains along [101].

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The molecular structure of the title compound with probability ellipsoids drawn at the 30% level.
Fig. 2.
Fig. 2.
Part of the crystal structure of the title compound with hydrogen bonds drawn as dashed lines.

References

    1. Altomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M. C., Polidori, G. & Camalli, M. (1994). J. Appl. Cryst.27, 435.
    1. Bhat, R., Xue, Y. F., Berg, S., Hellberg, S., Ormo, M., Nilsson, Y., Radesater, A. C., Jerning, E., Markgren, P. O., Borgegard, T., Nylof, M., Gimenez-Cassina, A., Hernandez, F., Lucas, J. J., Diaz-Nido, J. & Avila, J. (2003). J. Biol. Chem.278, 45937–45945. - PubMed
    1. Blessing, R. H. (1995). Acta Cryst. A51, 33–38. - PubMed
    1. Inestrosa, N. C., Farías, G. & Colombres, M. (2006). Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development, edited by A. Martinez, A. Castro & M. Medina, pp. 25–43. New Jersey: John Wiley & Sons Inc.
    1. Nonius (2002). COLLECT Nonius BV, Delft, The Netherlands.